Compare stocks
Add stockDates End of financial period
| #1 | #2 | #3 | #4 | #5 | #6 | #7 | #8 | |
|---|---|---|---|---|---|---|---|---|
| Remove Moderna, Inc. | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 |
Profit ROIC / ROE/ROA / ROE / ROA
| #1 | #2 | #3 | #4 | |
|---|---|---|---|---|
| Moderna, Inc. (ROE/ROA) | 5.5% | 5.4% | 6.1% | 7.3% |
Growth Sales and OCF growth / Sales and net income growth
| #1 | #2 | #3 | #4 | |
|---|---|---|---|---|
| Moderna, Inc. | 17.9% | 10.1% | -5.4% | -14.7% |
Payout Shareholder distributions / net income
| #1 | #2 | #3 | #4 | #5 | |
|---|---|---|---|---|---|
| Moderna, Inc. | 0% | 0% | 0% | 0% | 0% |
Safety Equity/assets and OCF stability / Equity/assets and net income stability
| Balance | Stability | |
|---|---|---|
| Moderna, Inc. | 67.2% | -73.6% |
Price Earnings and FCF yield / Earnings and book yield
| Earnings | FCF / Book | |
|---|---|---|
| Moderna, Inc. | $-4.99 | $-1.97 |
